XML 56 R46.htm IDEA: XBRL DOCUMENT v3.21.1
DEBT AND FINANCING COSTS - Additional Information (Details)
1 Months Ended 3 Months Ended
Nov. 30, 2018
option
Mar. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Feb. 28, 2019
USD ($)
Debt Instrument [Line Items]        
Outstanding borrowings   $ 657,000,000 $ 624,000,000 [1]  
Letters of credit outstanding   $ 2,000,000.0 0  
Line of Credit        
Debt Instrument [Line Items]        
Debt covenant term, maximum leverage ratio   5.00    
Debt covenant, period following qualified acquisition   1 year    
Debt covenant term, distributions limits   $ 30,000,000    
Debt covenant term, adjustment of consolidated net income limit for three consecutive calendar months on annualized basis   $ 350,000,000.0    
Debt actual leverage ratio   4.00    
Line of Credit | Maximum        
Debt Instrument [Line Items]        
Debt covenant term, maximum leverage ratio   5.50    
Line of Credit | Minimum        
Debt Instrument [Line Items]        
Debt covenant term, maximum leverage ratio   4.00    
Line of Credit | Revolving Credit Facility        
Debt Instrument [Line Items]        
Number of extension options | option 2      
Extended financing agreement term 1 year      
Debt maximum borrowing capacity   $ 1,500,000,000   $ 800,000,000.0
Outstanding borrowings   $ 657,000,000.0 $ 624,000,000.0  
Debt facility fee percentage   0.20%    
Line of Credit | Revolving Credit Facility | Base Rate        
Debt Instrument [Line Items]        
Debt instrument, basis spread on variable rate   0.05%    
Line of Credit | Revolving Credit Facility | London Interbank Offered Rate (LIBOR)        
Debt Instrument [Line Items]        
Debt instrument, basis spread on variable rate   1.05%    
Line of Credit | Letter of Credit        
Debt Instrument [Line Items]        
Debt maximum borrowing capacity   $ 100,000,000.0    
Line of Credit | Swingline Loan Subfacility        
Debt Instrument [Line Items]        
Debt maximum borrowing capacity   $ 100,000,000.0    
[1] The Consolidated Balance Sheet as of December 31, 2020 has been derived from the audited consolidated financial statements, revised to reflect the Company’s fair value change of its underlying warrants. Refer to Note 1—Summary of Significant Accounting Policies, see the section titled Revision of Previously Issued Consolidated Financial Statements for Immaterial Adjustment for further information.